Sector: Healthcare
Astellas is a global pharmaceutical company headquartered in Japan that focuses on the research, development, and commercialization of innovative medicines in areas such as oncology, urology, immunology, and neuroscience. The company operates worldwide, aiming to improve patient outcomes through advanced drug discovery and strategic partnerships.
We are tracking 1 layoff event for Astellas as of Apr 14, 2026.
Astellas is closing its Seattle stem cell therapy unit, impacting approximately 55 employees. The closure is part of a broader effort to consolidate
Healthcare
French biopharmaceutical firm Valneva is cutting up to 15% of its global workforce, impacting over 100 employees, following a significant revenue drop and
May 18, 2026
Read storyHealthcare
Takeda is implementing a global "transformation program" to streamline operations and cut costs, resulting in 4,500 job reductions worldwide.
May 14, 2026
Read storyHealthcare
INTEGRIS Health in Oklahoma confirms upcoming workforce reductions and clinic closures due to anticipated Medicaid and Medicare funding cuts.
Apr 17, 2026
Read storyHealthcare
Greenwood Leflore Hospital in Mississippi issued a WARN notice, warning employees of potential layoffs as the hospital prepares to close on June 15.
Apr 14, 2026
Read story